Search results
Results from the WOW.Com Content Network
Novartis, which is working on two other drug candidates to treat IgAN, added it plans to review the interim results with the U.S. Food and Drug Administration with a view to seeking accelerated ...
Innovation is the lifeblood of the big pharma industry. Without a robust drug development pipeline and ground-breaking medications that make their way through the complex FDA approval process ...
Novartis AG is a publicly traded Swiss holding company that operates through the Novartis Group and owns, directly or indirectly, all companies worldwide that operate as subsidiaries of the Novartis Group. [110] Novartis's businesses are divided into two operating divisions: Innovative Medicines and Sandoz (generics). [111]
Swiss drugmaker Novartis (NOVN.S) is moving further into gene therapy by buying AveXis (AVXS.O) for $8.7 billion, adding a rare-disease treatment that could reap billions in sales. The $218-per ...
Novartis Gene Therapies, until 2020 known as AveXis, is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in Dallas , Texas , United States in 2012 by John Carbona after reorganizing a company called BioLife Cell Bank founded by David Genecov and John Harkey.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Novartis is poised to prevail in the auction for Cytokinetics, ahead of other bidders that include AstraZeneca and Johnson & Johnson, according to the source. A deal could be announced as early as ...